dimanche 15 novembre 2026
RechercherExplore
fr.via.news
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· January 26, 2026

Stock market today: Dow, S&P 500, Nasdaq inch higher with big week of Big Tech earnings, Fed meeting ahead

View original at finance.yahoo.com
Stock market today: Dow, S&P 500, Nasdaq inch higher with big week of Big Tech earnings, Fed meeting ahead US stocks nudged higher on Monday, signaling cautious optimism on Wall Street as pressure built on the dollar ahead of a big week filled with a Federal Reserve rate decision and Big Tech earnings reports…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Investors can't not consider the risks of bottomless spending and sky-high valuations

    80% confidence

  • Tech sector issued nearly $700 billion in investment-grade debt over the past quarter, closing in on the just-over $800 billion in issuance by the financial sector

    80% confidence

  • Meta boosted spending projections from a range of $66 billion-$72 billion to between $70 billion and $72 billion

    80% confidence

  • Intel expects losses to continue into the first quarter

    80% confidence

  • Microsoft would spend more in 2026 than the $88.2 billion it spent in 2025

    80% confidence

  • Trump hinted he could name his choice of replacement for Powell as soon as this week

    80% confidence

  • The share of people citing an 'AI bubble' is falling

    80% confidence
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,959
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,959 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Stock market today: Dow, S&P 500, Nasdaq inch higher with big week of Big Tech earnings, Fed meeting ahead: Source | Via News | fr.via.news